Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Stroke. 2010 Aug 19;41(10):2265–2270. doi: 10.1161/STROKEAHA.110.592295

Table 2.

Baseline demographics and risk factors between the hypothermia and normothermia groups. (* peripheral vascular disease)

Hypothermia (Group 2, 5, 6) n=28 Normothermia (Group 1, 3,4) n=30 Fisher’s Exact Test p-value:
Male gender 56.7% 53.8% 0.999
Race (white) 89.3% 80.0% 0.707
Age in years (±SD) 68.9 (7.9) 62.3 (14.5) 0.109
Known atrial fibrillation 21.4% 13.3% 0.499
Diabetes 21.4% 30.0% 0.554
Arterial hypertension 71.4% 63.3% 0.583
Hyperlipidemia 53.7% 50.0% 0.793
Present smoking 10.7% 26.7% 0.102
Congestive heart failure 3.6% 16.7% 0.109
PVD* 3.6% 6.7% 0.411
Myocardial infarction 14.3% 16.7% 0.426
Coronary artery disease 39.4% 26.7% 0.695
Prior stroke or TIA 17.9% 20.0% 0.869
Liver disease 3.6% 0 0.229
Lung disease 10.7% 13.3% 0.848
Renal disease 7.1% 13.3% 0.671
Gastrointestinal disease 21.4% 33.3% 0.298
Pre-stroke Modified Rankin >1 14.3% 3.3% 0.214
Pre-treatment NIHSS (±SD) 14.3(5.0) 13.7(5.1) 0.651
*

Peripheral Vascular Disease